Changes in circulating lymphocyte subpopulations in pigs receiving therapeutic doses of ceftiofur and tulathromycin

1. Altunok V., Yazar E., Elmas M., Traş B., Baş A.L., Cöl, R.: Investigation of haematological and biochemical side effects of tilmicosin in healthy New Zealand rabbits. J Vet Med Series B 2002, 49, 68-70.10.1046/j.1439-0450.2002.00502.x12002421Search in Google Scholar

2. Bazzoni F., Beutler B.: The tumor necrosis factor ligand and receptor families. New Engl J Med 1996, 334, 1717-1725.10.1056/NEJM1996062733426078637518Search in Google Scholar

3. Bergeron Y., Ouellet N., Deslauriers A.M., Simard M., Olivier M., Bergeron M.G.: Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice. Antimicrob Agents Chemother 1998, 42, 2527-2533.10.1128/AAC.42.10.25271058799756751Search in Google Scholar

4. Chang C.F., Chang L.C., Chang Y.F., Chen M., Chiang T.S.: Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Escherichia coli, and Salmonella choleraesuis recovered from Taiwanese swine. J Vet Diagn Invest 2002, 14, 153-157.10.1177/10406387020140021011939337Search in Google Scholar

5. Chrząstek K., Madej J.P., Mytnik E., Wieliczko A.: The influence of antibiotics on B-cell number, percentage, and distribution in the bursa of Fabricius of newly hatched chicks. Poult Sci 2011, 90, 2723-2729.10.3382/ps.2011-0152522080010Search in Google Scholar

6. Chrząstek K., Wieliczko A.: The influence of enrofloxacin, florfenicol, ceftiofur and E. coli LPS interaction on T and B cells subset in chicks. Vet Res Commun 2015, 39, 53-60.10.1007/s11259-015-9632-7433046425686865Search in Google Scholar

7. Ci X., Li H.Y., Song Y., An Y., Yu Q., Zeng F., Deng X.: Ceftiofur regulates LPS-induced production of cytokines and improves LPS-induced survival rate in mice. Inflammation 2008, 31, 422-427.10.1007/s10753-008-9094-y18989766Search in Google Scholar

8. Clinical and Laboratory Standards Institute. Reference leukocyte (WBC) differential count (proportional) and evaluation of instrument methods; Approved standard 2007, 27.Search in Google Scholar

9. Committee for Veterinary Medicinal Products Summary Report: Ceftiofur. The European Agency for the Evaluation of Medicinal Products EMEA/CVMP/80785/2006-Final.Search in Google Scholar

10. Committee for Veterinary Medicinal Products Summary Report: Tulathromycin. The European Agency for the Evaluation of Medicinal Products EMEA/MRL/842/2002-Final.Search in Google Scholar

11. Duquette S.C., Fischer C.D., Williams A.C., Sajedy S., Feener T.D., Bhargava A., Reti K.L., Muench G.P., Morck D.W., Allison J., Lucas M.J., Buret A.G.: Immunomodulatory effects of tulathromycin on apoptosis, efferocytosis, and proinflammatory leukotriene B4 production in leukocytes from Actinobacillus pleuropneumoniae-or zymosan-challenged pigs. Am J Vet Res 2015, 76, 507-519.10.2460/ajvr.76.6.50726000598Search in Google Scholar

12. Er A., Altan F., Cetin G., Dik B., Elmas M., Yazar E.: Assessment of the cardiotoxicity of tulathromycin in rabbits. Acta Vet Hung 2011, 59, 327-335.10.1556/avet.2011.01521727065Search in Google Scholar

13. Evans N.A.: Tulathromycin: an overview of a new triamilide antibiotic for livestock respiratory disease. Vet Ther 2005, 6, 83-95.Search in Google Scholar

14. Fernandez Filho T., Favaro C Jr., Ingberman M., Beirao B.C.B., Inoue A., Gomes L., Caron L.F.: Effect of spray Escherichia coli vaccine on the immunity of poultry. Avian Dis 2013, 57, 671-676.10.1637/10456-112612-ResNote.124283136Search in Google Scholar

15. Fischer C.D., Beatty J.K., Duquette S.C., Morck D.W., Lucas M.J., Buret A.G: Direct and indirect anti-inflammatory effects of tulathromycin in bovine macrophages: inhibition of CXCL-8 secretion, induction of apoptosis, and promotion of efferocytosis. Antimicrob Agents Chemother 2013, 57, 1385-1393.10.1128/AAC.01598-12359187223295921Search in Google Scholar

16. Fischer C.D., Beatty J.K., Zvaigzne C.G., Lucas M.J., Buret A.G.: Anti-inflammatory benefits of antibiotic-induced neutrophil apoptosis: tulathromycin induces caspase-3-dependent neutrophil programmed cell death and inhibits NF-kappaB signaling and CXCL8 transcription. Antimicrob Agents Chemother 2011, 55, 338-348.10.1128/AAC.01052-10301964520956586Search in Google Scholar

17. Hao Z., Zhao Y., Wu H., Hao L., Ding Z., Yang F., Qu B.: The physiological and biochemical evaluation of tulathromycin premix in pigs. J Anim Vet Adv 2012, 11, 4161-4166.Search in Google Scholar

18. Mangano K., Quattrocchi C., Aiello C., Scalia G., Speciale A., Nicoletti G., Di Marco R.: Immunomodulatory properties of cefaclor: in vivo effect on cytokine release and lymphoproliferative response in rats. J Chemother 2006, 18, 641-647.10.1179/joc.2006.18.6.64117267343Search in Google Scholar

19. Nutsch R.G., Hart F.J., Rooney K.A., Weigel D.J., Kilgore W.R., Skogerboe T.L.: Efficacy of tulathromycin injectable solution for the treatment of naturally occurring swine respiratory disease. Vet Ther 2005, 6, 214-224.Search in Google Scholar

20. Pomorska-Mól M., Pejsak Z.: Effect of therapeutic doses of enrofloxacin on circulating lymphocyte subpopulations in pigs. Bull Vet Inst Pulawy 2015, 59, 287-293.10.1515/bvip-2015-0042Search in Google Scholar

21. Pomorska-Mól M., Czyżewska-Dors E., Kwit K., Wierzchosławki K., Pejsak Z.: Ceftiofur hydrochloride affects the humoral and cellular immune response in pigs after vaccination against swine influenza and pseudorabies. BMC Vet Res 2015, 11, 268.10.1186/s12917-015-0586-3461868126493336Search in Google Scholar

22. Pomorska-Mól M., Kwit K., Wierzchosławki K., Dors A., Pejsak Z.: The effect of amoxicillin, ceftiofur, doxycycline, tiamulin and tulathromycin on swine humoral immune response induced by erysipelas vaccination. Vet Rec 2016, 178, 559.10.1136/vr.10353327072375Search in Google Scholar

23. Pomorska-Mól M., Czyżewska-Dors E., Kwit K., Pejsak Z.: Enrofloxacin decreases IL-6 and TNF-á production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells. J Vet Res 2016 60, 189-193.10.1515/jvetres-2016-0028Search in Google Scholar

24. Ratzinger F., Haslacher H., Poeppl W., Hoermann G., Kovarik J.J., Jutz S., Steinberger P., Burgmann H., Pickl W.F., Schmetterer KG.: Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. Sci Rep 2014, 4, 7438.10.1038/srep07438426288425500904Search in Google Scholar

25. Villiger P.M., Cronin M.T., Amenomori T., Wachsman W., Lotz M.: IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells. J Immunol 1991, 146, 550-559. 10.4049/jimmunol.146.2.550Search in Google Scholar